24 April 2013 – Global Sample Management Workshop – Orlando, FL, US
Sample Management Outsourcing Strategies: Improving Efficiencies and Achieving Cost Savings
Date: Wednesday, April 24, 2013
Time: 7:30 AM – 9:00 AM
Venue: Anaheim Room, The Marriott World Center
Location: IIR Partnerships in Clinical Trials, Orlando, FL
The optimization of research samples to support future drug discovery and development is gaining in importance due to the increasing trend toward personalized medicine and the lack of growth in research budgets that is occurring within the biopharmaceutical industry. Research companies are
being challenged to generate research innovation, process efficiencies and quality improvements that move the right drugs to market more quickly – while still achieving cost savings. New strategies are emerging in the area of global outsourcing of research samples which are enabling companies to reduce unnecessary expenditures and to focus on reinvesting in their core.
Learn from experts in various segments of the biosciences industry on how they have developed strategic partnerships to improve efficiencies and reduce the costs of sample management to support research and development. This indepth, interactive workshop will enable shared learning on:
- How to identify and leverage an academic outsourcing partner to generate research efficiencies and cost savings while advancing research initiatives
- Strategies for successful outsourcing of logistics and storage of research sample management in Asia-Pacific
- Examples of how to optimize sample management solutions through global consolidation and utilization of flexible outsourcing models
- How to better integrate internally in order to improve efficiencies of sample management along the research value chain
|Lori A. Ball, COO, Biostorage Technologies, Inc.As the Chief Operating Officer, Ball leads the successful development and execution of BioStorage Technologies global biorepository operations and logistics expansion strategies, comprehensive sample management solutions, global strategic marketing and business development and the design and delivery of innovative technology solutions.Ball brings over 25 years of consumer products, CRO and pharmaceutical services industry experience to BioStorage Technologies and she has a strategic role in the overall management and growth of the company. Her leadership has enabled the company to achieve year-over-year double-digit revenue growth and to increase its scale of operations through the expansion of facilities, growth in staffing and development of talent, increasing the company’s footprint into new geographies and integration of new service capabilities.Formerly at Covance, Inc., she had a proven track record of sales and revenue growth serving as the global head of sales and business development and the global head of supply chain management and logistics. In these roles, she was responsible for overseeing multiple lines of management, leading market expansion into new industry sectors and geographies, developing profitable logistics partnerships and introducing innovative global sales force automation and sales techniques to the organization.Ball serves on many industry impact initiatives and is a recognized expert and speaker. She earned an M.B.A. from Indiana Wesleyan University and a B.A. from Anderson University and holds Six Sigma process improvement credentials.|
|Dr. Andrew Brooks, Chief Operating Officer, RUCDR Infinite Biologics at Rutgers University
As the Chief Operating Officer of RUCDR Infinite Biologics, Dr. Andrew Brooks oversees the operations of all laboratories within RUCDR, ensuring consistent and superior quality standards for all services.
Since joining RUCDR, he has worked to automate and develop the service infrastructure to provide high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally. His methodologies focus on extending the use of valuable samples by extracting and renewing limited quantities of biomaterial with newly developed technologies.Dr. Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. These studies investigate gene-environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analysesDr. Brooks is the Director of the Bionomics Research and Technology Center (BRTC) at the Environmental and Occupational Health Science Institute of the University of Medicine and Dentistry of New Jersey. He is an Associate Professor of Environmental Medicine and Genetics at UMDNJ/Rutgers. He received his Ph.D. from the University of Rochester, School of Medicine.
|Rey Roman, Vice President, Regulatory Compliance and Technical Affairs, Marken
Rey Roman, Senior Manager of Regulatory Compliance, is a licensed U.S. Customs Broker and Certified Customs Specialist with more than seventeen years of experience in the customs brokerage and trade compliance field. In his current role, Rey supports Marken operations and business development teams in ensuring that the import and regulatory requirements set forth by Customs and Border Protection and other government agencies are met.
Prior to joining Marken, Rey built a career in U.S. Customs brokerage and trade compliance which included managing Customs’ brokerage teams and aiding U.S. importers to develop trade strategies and best practices. His experience helps to ensure a smooth import process which will result in a more timely and cost-efficient delivery of our clients’ imports.
|Amelia Wall Warner, Head Clinical Pharmacogenomics and Clinical Specimen Management, Merck & Co.
Amelia Wall Warner, PharmD is Head of Clinical Pharmacogenomics and Clinical Specimen Management for Merck Research Laboratories. Dr. Warner oversees all clinical pharmacogenomics projects, oversees policies and procedures for biosample collection and storage for clinical trial samples, and is co-chair of the pharmacogenomics Strategic Scientific Oversight Committee. She is the current co-lead of the Pharmacogenomics Integration Workstream for Merck and will be setting up the new department of Clinical Pharmacogenomics and Clinical Specimen Management.Amelia completed a residency in Pediatric Pharmacotherapy at St. Jude Children’s Research Hospital with John Rodman, PharmD and a fellowship in Clinical Pharmacology/ Pharmacogenomics at St. Jude Children’s Research Hospital with William Evans, PharmD. Amelia holds a PharmD from the University of North Carolina at Chapel Hill and a Bachelor of Science in Biology from Wake Forest University. She is the immediate past chair of the Industry Pharmacogenomics Working Group (I-PWG) and is a PhRMA representative to ICH E16.
|Karen McNamara, Clinical Supply Manager, Infinity Pharmaceuticals, Inc.
Karen McNamara is a Clinical Supply Manager at Infinity Pharmaceuticals, Inc. where she is responsible for timely preparation and delivery of clinical trial materials for global clinical trials which include activities such as labeling, packaging, distribution, and inventory management. Additionally, Karen has recently been tasked with overseeing sample management activities at Infinity. As part of this new responsibility, Karen is responsible for identifying and implementing efficiencies across the sample lifecycle and associated systems and/or processes.Karen has worked in the biotech/pharma industry for the past 7 years. Before joining Infinity about two years ago, Karen was with Biogen Idec as a Clinical Logistics Manager overseeing a team of 5 responsible for distribution to over 30 clinical trials being conducted in over 30 countries worldwide. Karen started her biotech/pharma career at Biogen Idec as a Logistics Analyst responsible for developing and executing supply chain shipping qualifications, including ground and air transport at various temperature and time profiles as required by product needs.